Skip to content

Evaluation of the clinical effect of immunotherapy in bronchial asthma: a prospective cohort study

Evaluation of the clinical effect of immunotherapy in bronchial asthma: a prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056772
Enrollment
Unknown
Registered
2022-02-15
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

asthma patient:no

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with asthma according to the guidelines; (2) Patients with allergic bronchial asthma diagnosed by a doctor; (3) Moderate and severe patients with allergic bronchial asthma who are still unable to effectively control their symptoms after inhaled ICS and long-acting ß2-adrenoceptor agonists.

Exclusion criteria

Exclusion criteria: (1) Acute exacerbation of bronchial asthma; (2) There is no clear evidence to prove allergic bronchial asthma; (3) Mild to moderate patients with allergic bronchial asthma whose symptoms can be effectively controlled by inhaled ICS and long-acting ß2-adrenoceptor agonists.

Design outcomes

Primary

MeasureTime frame
ACQ7;ACT;cytokine;lung function;

Countries

China

Contacts

Public ContactLiu Yi

Shandong Provincial Hospital Affiliated to Shandong University

yiliu_sdu@163.com+86 15168888626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026